Raffaella Buzzetti


Titolo Pubblicato in Anno
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status THE AMERICAN JOURNAL OF CARDIOLOGY 2022
Development of a clinical risk score to predict death in patients with COVID-19 DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Third dose of Covid-19 vaccine in diabetes: relevance of good metabolic control to improve its efficacy DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Gender-sex differences in autoimmune atrophic gastritis TRANSLATIONAL RESEARCH 2022
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2022
Corneal confocal microscopy identifies small nerve fibre damage in patients with hypertriglyceridemia JOURNAL OF CLINICAL LIPIDOLOGY 2022
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective DIABETES, OBESITY AND METABOLISM 2022
IDegLira for the Real-World Treatment of Type 2 Diabetes in Italy: Protocol and Interim Results from the REX Observational Study DIABETES THERAPY 2022
Role of continuous glucose monitoring in diabetic patients at high cardiovascular risk: an expert-based multidisciplinary Delphi consensus CARDIOVASCULAR DIABETOLOGY 2022
Contribution of rare variants in monogenic diabetes-genes to early-onset type 2 diabetes DIABETES & METABOLISM 2022
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study ANTIOXIDANTS 2022
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I DIABETES/METABOLISM RESEARCH AND REVIEWS 2022
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA FRONTIERS IN ENDOCRINOLOGY 2022
Adult-onset autoimmune diabetes NATURE REVIEWS. DISEASE PRIMERS 2022
Comparative effectiveness and safety of glargine 300 U/mL versus degludec 100 U/mL in insulin-naïve patients with type 2 diabetes. A multicenter retrospective real-world study (RESTORE-2 NAIVE STUDY) ACTA DIABETOLOGICA 2022
Differential involvement of myelinated and unmyelinated nerve fibers in painful diabetic polyneuropathy MUSCLE & NERVE 2021
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes: A cross-sectional study DIABETIC MEDICINE 2021
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths DIABETES RESEARCH AND CLINICAL PRACTICE 2021
Similar glycaemic control and risk of hypoglycaemia with patient- versus physician-managed titration of insulin glargine 300 U/mL across subgroups of patients with T2DM: a post hoc analysis of ITAS ACTA DIABETOLOGICA 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma